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Histone acetylation and deacetylation play essential
roles in modifying chromatin structure and regulating
gene expression in eukaryotes. Histone deacetylases
(HDACs) catalyze the deacetylation of lysine residues in
the histone N-terminal tails and are found in large multi-
protein complexes with transcriptional co-repressors.
Human HDACs are grouped into three classes based on
their similarity to known yeast factors: class I HDACs
are similar to the yeast transcriptional repressor yRPD3,
class II HDACs to yHDA1 and class III HDACs to ySIR2. In
this review, we focus on the biology of class II HDACs.
These newly discovered enzymes have been implicated
as global regulators of gene expression during cell dif-
ferentiation and development. We discuss their emerg-
ing biological functions and the molecular mechanisms
by which they are regulated.
The DNA of eukaryotic cells in chromatin is tightly
wrapped around octamers of histone proteins, restricting
its accessibility to factors involved in DNA replication and
transcription. Local or extended structural changes in
chromatin play an important role in the control of gene
expression and are governed by complexes that remodel
chromatin and by enzymes that posttranslationally modify
histones (reviewed in Ref. [1]).
All core histone proteins are reversibly and dynamically
acetylated at multiple sites in their N-terminal tails.
Hyperacetylated histones are generally found in tran-
scriptionally active genes and hypoacetylated histones in
transcriptionally silent regions, such as heterochromatin.
The level of histone acetylation at a particular locus
in chromatin reflects the competing activities of histone
acetyltransferases and histone deacetylases (HDACs). The
identification and characterization of numerous transcrip-
tional regulators possessing histone acetyltransferase or
HDAC activities has validated the prediction that histone
acetylation plays a critical role in transcriptional regulat-
ory mechanisms (for general reviews see Ref. [2]).
Eighteen distinct human HDACs are grouped into
three classes based on their primary homology to three
Saccharomyces cerevisiae HDACs. Class I HDACs
(HDAC1, -2, -3, -8 and -11) are homologous to yRPD3,
share a compact structure, and are predominantly nuclear
proteins expressed in most tissues and cell lines (Fig. 1a)
(reviewed in Ref. [3]). Class II HDACs, the subject of this
review, are homologous to yHDA1 and are subdivided into
two subclasses, IIa (HDAC4, -5, -7 and -9 and its splice
variant MITR) and IIb (HDAC6 and HDAC10), based on
sequence homology and domain organization (Fig. 1a,b)
[4–12]. Whereas class I and II HDACs and their
Fig. 1. Organization of class II histone deacetylases (HDACs) (a) Phylogenic tree
analysis of known mammalian HDACs and their yeast orthologs for the HDAC
class I and II families (adapted from Ref. [11]). The human proteins are preceded
by h, the yeast proteins by y and the prokaryotic proteins by pro. (b) Schematic
structure of class II HDACs. The class IIa HDACs, HDAC4, -5, -7 and -9, and MITR
(an HDAC9 splice variant), share an N-terminal domain of ,450–600 amino acids.
Domains in this region mediate interactions with the transcriptional co-repressor
CtBP, the MEF2 family of transcription factors, and others (see Fig. 2 for further
details). Conserved phosphorylation sites that play a crucial role in nuclear/ cyto-
plasmic shuttling are indicated. The class IIb HDACs, HDAC6 and HDAC10, are
characterized by the presence of two tandemly arranged HDAC domains (the
second domain is truncated in the case of HDAC10).
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S. cerevisiae orthologs, yRPD3 and yHDA1, all share some
degree of homology in their catalytic domain, class III
HDACs are homologous to ySIR2 and show no homology to
class I and II proteins.
The class IIa HDACs: HDAC4, -5, -7 and -9
HDAC4, -5, -7 and -9 contain a highly conserved
C-terminal catalytic domain (,420 amino acids) homo-
logous to yHDA1 and an N-terminal domain with no
similarity to other proteins (Fig. 1b) [4–7,13]. MITR, a
splice variant of HDAC9, consists of only its N-terminus
without an HDAC domain. The activity of the class IIa
HDACs is regulated at several levels, including tissue-
specific gene expression, recruitment of distinct cofactors
and nucleocytoplasmic shuttling.
Tissue-specific expression
Whereas most class I HDACs are ubiquitously expressed,
the class IIa HDACs are expressed in a restricted number
of cell types. Three of the class IIa HDACs, HDAC4, -5
and -9, show highest expression in heart, skeletal muscle
and brain, where their biological activities might be
partially redundant [4,5,7,13–15]. In contrast to initial
reports describing highest HDAC7 expression in heart
and lung tissues [16,17], we have recently observed that
HDAC7 is most highly expressed in CD4/CD8 double-
positive thymocytes (F. Dequiedt et al., unpublished).
Interaction partners
HDACs represent the catalytic components of large multi-
protein complexes. They do not bind directly to DNA and
are thought to be recruited to specific promoters through
their interaction with DNA sequence-specific transcrip-
tion factors (Fig. 2). The MEF2 family of transcription
factors is one of the major targets of class IIa HDACs
and will be discussed in detail below (see section on the
biological role of HDACs). Other interactions occur with
CtBP (E1A C-terminal binding protein), 14-3-3 proteins,
calmodulin (CaM), transcriptional co-repressors, hetero-
chromatin protein HP1a and SUMO.
CtBP1 was originally identified as an adenovirus E1A
interacting protein and later found to interact with several
Drosophila DNA-binding proteins, including Hairy, Snail,
Kru¨ppel and mammalian basic Kru¨ppel-like factor 3
(BKLF/KLF3) (reviewed in Ref. [18]). CtBP associates
with each of these proteins, as well as with HDAC4 and -5
and MITR, through a PXDLS motif, and acts as a
transcriptional repressor [19]. However, since CtBP can
still repress transcription in the absence of HDAC activity,
the precise mechanism of CtBP-mediated transcriptional
repression remains unclear [18].
The class IIa HDACs all interact with 14-3-3 proteins
[20–24]. This interaction plays a critical role in the
nucleocytoplasmic shuttling of class II HDACs (see section
on dynamic subcellular localization for an in depth dis-
cussion of the role of 14-3-3 proteins).
The MEF2-binding domain of HDAC4 shares some
features with known CaM-binding domains [25]. HDAC4
binds to CaM in vitro, and binding of CaM disrupts the
MEF2–HDAC4 interaction. This mechanism could con-
tribute to the Ca2þ-dependent activation of MEF2 [26];
however, the significance of these observations for the
biology of class IIa HDACs remains to be assessed.
Class II HDACs interact with two closely related
co-repressors, SMRT (silencing mediator for retinoid
and thyroid receptors) and N-CoR (nuclear receptor
co-repressor). This interaction is critical for the enzymatic
activity of class IIa HDACs and is discussed separately
below. In addition, the N-terminal BTB/POZ domain of
BCL6, a sequence-specific transcriptional repressor with
Kru¨ppel-like zinc-finger motifs that is involved in the
pathogenesis of non-Hodgkin’s B-cell lymphomas [27,28],
can bind either to SMRT, leading to the recruitment of the
SMRT/N-CoR co-repressor complex [29–31], or to B-CoR,
another co-repressor protein [32]. Therefore, class IIa
HDACs might modulate the transcriptional repression of
BCL6 and participate in its role in B-cell activation and
differentiation, inflammation, and cell-cycle regulation
[33]. BCL6 also interacts directly with a conserved region
in the N-terminal domain of class IIa HDACs [34] (Fig. 2).
Fig. 2. Interaction partners of class IIa histone deacetylases (HDACs). Class IIa HDACs interact with several partners through distinct domains. The N-terminal domain is
used primarily as a targeting domain for distinct promoters by the MEF2 transcription factors. Interaction of class IIa HDACs with HP1, CtBP and the SMRT/N-CoR and
B-CoR co-repressor complexes mediates the transcriptional repressive activities of class II HDACs.
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Thus, class IIa HDACs can be recruited to Bcl-6-regulated
promoters by two mechanisms: direct interaction with
BCL6 or indirect recruitment through co-repressors such
as SMRT/N-CoR and B-CoR. It is not clear why B-CoR and
BCL6 interact with such a disparate array of class I and
class II HDACs. Further experiments are needed to assess
the biological relevance of these observations.
HDAC4 and -5 and MITR interact with HP1a. The
interaction is mediated by an N-terminal domain that is
distinct from other interacting sites on class II HDACs
(Fig. 2). HP1 contains a chromodomain involved in the
specific recognition of methylated lysine 9 of histone.
HP1 also interacts with the histone methyltransferase
SUV39H1. Since histone H3 must be deacetylated before it
can be methylated, these observations suggest that the
class II HDAC–HP1 interaction could be important in the
establishment and maintenance of heterochromatin [35].
Finally, HDAC4, MITR and HDAC6 associate with
and become modified by SUMO-1, a ubiquitin-like protein
[36,37]. The biological significance of this modification has
not been established.
Dynamic subcellular localization
All class IIa HDACs shuttle between the nucleus and the
cytoplasm [6,20,21,23,26,38–40]. Class IIa HDACs bind
to 14-3-3 proteins, a family of highly conserved acidic
proteins (reviewed in Ref. [41]). This binding is depen-
dent on the phosphorylation of two or three conserved
N-terminal serine residues in class IIa HDACs and medi-
ates their cytoplasmic sequestration (Fig. 1b) [20,21,23];
mutation of these sites prevents the export of class IIa
HDACs from the nucleus to the cytoplasm [20–24,40,42]
(Fig. 1b). The sequences of the phosphorylation sites in
class IIa HDACs are closely related to consensus phos-
phorylation sites for Ca2þ/CaM-dependent protein kinases
(CaMKs) [43], and CaMK-mediated phosphorylation of
HDAC4, -5, -7 and -9 promotes their association with
14-3-3 proteins and stimulates their nuclear export to the
cytoplasm [21–24,44]. Recent experiments in cardiomyo-
cytes indicate that an unidentified HDAC kinase targets
the same phosphorylation sites in class IIa HDACs in
response to hypertrophic signals [45].
It is thought that 14-3-3 proteins modify the subcellular
localization of targets by interfering with nuclear import
and export signals. A nuclear import signal containing
an arginine/lysine-rich motif has been mapped in HDAC4
(amino acids 251–272) and -5 (amino acids 264–285)
[26,46], and appears to be conserved in HDAC7 and
MITR/HDAC9. Phosphorylation-dependent binding of
14-3-3 proteins to the N-termini of class II HDACs
masks the nuclear import signal and prevents nuclear
import. A CRM1-dependent nuclear export signal has been
mapped in HDAC4 (amino acids 1056–1069) and HDAC5
(amino acids 1086–1099) [44,46]. This nuclear signal
becomes active upon binding of 14-3-3 proteins to the
N-terminus of class II HDACs. These observations suggest
that phosphorylation of the N-terminus of class IIa HDACs
and/or recruitment of 14-3-3 proteins induces a long-
distance conformational change that unmasks a latent
nuclear export signal in their C-terminus.
The nucleocytoplasmic shuttling of class II HDACs
regulates their activities as transcriptional repressor
proteins. Overexpression of constitutively active CaMKs
or signal-dependent activation of CaMKs induces the
relocalization of class IIa HDACs to the cytoplasm and
suppresses their repressive activity [22,47]. By contrast,
mutation of the phosphorylation sites of class IIa HDACs
abolishes their cytoplasmic export and enhances their
repressive effects during muscle differentiation and T-cell
apoptosis [40,43]. Cytoplasmic relocalization of class II
HDACs removes these enzymes from their substrates –
the histone proteins in chromatin – and dissociates them
from the SMRT/N-CoR–HDAC3 complex, leading to
their enzymatic inactivation, as discussed in the next
section [16,48].
Regulation of HDAC catalytic activity
Class IIa HDACs interact directly with SMRT and N-CoR
through their C-terminal HDAC domains [17,49,50]. Both
SMRT and N-CoR interact with unbound nuclear receptors
and with a growing list of other transcription factors
(reviewed in Ref. [51]). In addition, both SMRT and N-CoR
participate in the formation of a stable multiprotein com-
plex consisting of HDAC3, transducin (b)-like 1 (TBL1)
[52,53] and GPS2, a protein involved in intracellular
signaling [54]. A recent proteomic analysis of the com-
ponents of the S. cerevisiae SET3 complex showed the
presence of two HDACs, Hos2 and Hst1 [55]. Hos2 is
related to the yeast Hda1 deacetylase, while Hst1 is a
Sir2-like protein with NAD-dependent deacetylase activity.
The SET3 complex also contains a WD40 protein with
homology to TBL1, suggesting that this complex is a
yeast ortholog of the SMRT/NCoR complex. It is not clear
at this point why multiple HDACs from different classes
are assembled in a single multiprotein complex. Distinct
enzymes might confer unique substrate specificities to the
complex. The dependency of class III enzymes on NADþ
could also link the activity of the complex to the metabolic
status of the cell. A similar combination of class II and
class III enzymes in a multiprotein complex was recently
observed for HDAC6 and SIRT2, a human class III
HDAC [56].
SMRTandN-CoRinteractbothwith class IIaHDACs and
with HDAC3 through distinct domains [52,53,57,58], an
observation that explains why class IIa HDACs coimmuno-
precipitate with HDAC3 [5,16,48]. Class IIa HDACs are
enzymatically inactive alone as purified recombinant
proteins. However, they are associated with enzymatic
activity when bound to the SMRT/N-CoR–HDAC3 com-
plex [16,48]. HDAC3 is also catalytically inactive alone as
purified protein but becomes enzymatically active when
bound to SMRT/N-CoR, even in the absence of a class IIa
HDAC [48,58]. By contrast, class IIa HDACs alone are still
enzymatically inactive after binding to the SMRT/N-CoR
proteins in vitro.
This evidence is compatible with two models. First,
class IIa HDACs might not be functional HDACs in the
context of the SMRT/N-CoR complex but might serve to
recruit pre-existing, enzymatically active SMRT/N-CoR
complexes that contain HDAC3. In this model, the
SMRT/N-CoR co-repressors provide a structural link
between active HDAC3 and inactive class IIa HDACs. In
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a second model, class II HDACs might become activated
only in the presence of HDAC3. There is extensive
evidence for HDAC–HDAC interactions: the solved struc-
ture of Rpd3 shows a dimer, HDAC1 and -2 are found in
the same multiprotein complex, and HDAC6 contains
two tandemly arranged HDAC domains. These inter-
actions might indicate that HDAC–HDAC interactions
are important for the regulation of HDAC activity.
Interestingly, we have noted that several mutations
in amino acids that form the catalytic pocket of
class IIa HDACs also result in a loss of interaction with
SMRT/N-CoR. These observations suggest the existence
of interactions between amino acids in the catalytic center
of class IIa HDACs and the surface of these proteins. Such
interactions could regulate the enzymatic activity of the
enzyme as a function of its interactions with other proteins
and could ensure that the HDACs only become enzym-
atically active after incorporation in the appropriate
multiprotein complex.
Biological roles of class IIa HDACs
The many interactions between class IIa HDACs and
transcriptional regulators suggest a wide variety of poten-
tial biological roles. However, most of these interactions
have not been examined in a biological context. By con-
trast, the importance of interactions between MEF2 and
class IIa HDACs has been demonstrated in several tissue
culture and animal models. MEF2 plays a significant
transcriptional regulatory role in myogenesis, in negative
selection of developing thymocytes, and in the transcrip-
tional regulation of Epstein–Barr virus (EBV) (for a
complete review see Ref. [59]). The striking similarity of
MEF2 regulation in neurons and its role in neuronal
resistance to excitotoxicity suggests that class IIa HDACs
also play a significant role in neurons [60–62].
Class IIa HDACs inhibit myogenesis by binding to
MEF2 at several promoters critical for the muscle dif-
ferentiation program (for recent reviews see Refs [63,64]).
HDAC4, -5, -7 and -9 interact with MEF2 proteins through
a highly conserved 17 amino acid motif located in their
N-termini [7,23,38,65,66]. Expression of an HDAC–VP16
fusion protein, in which the VP16 activation domain
replaces the catalytic domain of HDAC4 or -5, enhances
myogenic conversion [47]. Activation of the CaMK signal-
ing pathway also overcomes the HDAC-mediated repres-
sion of muscle-specific gene expression and induces the
myogenic conversion program [22,64]. Further evidence
for the role of class IIa HDACs in cardiac and skeletal
myogenesis comes from the phenotype of HDAC9-deficient
animals. A phosphorylation mutant of HDAC9 in the
CaMK IV sites inhibits the myogenic program [24].
Conversely, HDAC9-deficient mice show a striking sus-
ceptibility to stress-induced cardiac hypertrophy [45]. In
cardiomyocytes, phosphorylation mutants of HDAC5 or
MITR block the induction of hypertrophy-associated genes
in response to phenylephrine [45]. These observations
suggest that class IIa HDACs are master regulators of
myocyte development. Bound to MEF2 proteins in the
promoters of multiple genes, they play a critical role in
repressing these genes until the appropriate myogenic
differentiation signal is delivered.
In the thymus, developing CD4/CD8 double-positive
T cells that receive a strong signal from major histo-
compatibility complex (MHC)–self-peptide through their
antigen receptors are deleted by an apoptotic process
termed negative selection. The apoptotic process is acti-
vated by the expression of Nur77, an orphan steroid
receptor [67–69]. Constitutive expression of Nur77 in
thymocytes results in a dramatic involution of the thymus,
whereas expression of a dominant-negative Nur77 inter-
feres with negative selection [70,71]. The expression
of Nur77 in response to antigen receptor signals is
tightly controlled through two MEF2-binding sites in
the Nur77 promoter (Fig. 3) [72]. As in other systems,
MEF2-dependent transcription in T cells is activated
by Ca2þ signals and by ectopic expression of activated
CaMK IV, calcineurin, or ERK5/BMK1 [73–75].
A MEF2-family protein, MEF2-D, is expressed in
thymocytes and associates with both HDAC4 and Cabin-1
under basal conditions in T-cell lines (Fig. 3) [25,74,76,77].
Activation of T-cell receptors disrupts the interaction
of MEF2-D with HDAC4 and Cabin-1, most probably
through a Ca2þ signal and CaM activation. HDAC7 is
highly expressed in CD4/CD8 double-positive thymocytes,
which undergo positive or negative selection (Fig. 3)
(F. Dequiedt et al., unpublished). HDAC7 also associates
with MEF2-D in CD4/CD8 double-positive T cells,
becomes dissociated from MEF2-D during T-cell acti-
vation and shuttles out of the nucleus. The nuclear
export of HDAC7 in thymocytes is dependent on three
serine residues in the N-terminus of the protein, as
described above for other class IIa HDACs. HDAC7
overexpression suppresses Nur77 induction and thy-
mocyte apoptosis in response to activation of T-cell
receptors. Conversely, expression of an HDAC7–VP16
fusion activates Nur77 expression in the absence of
such activation, and knockdown of HDAC7 through
RNA interference leads to increased apoptosis in response
to T-cell receptor activation. These findings, combined
with the recent finding that deletion of the MEF2-
interacting domain of Cabin-1 results in no detectable
phenotype with respect to thymic negative selection [78],
suggest that HDAC7 plays a critical role in the repression
of Nur77 during thymic maturation of T cells. Studies are
currently under way to validate these observations in
transgenic and knockout mice.
EBV is a human herpesvirus capable of latently infect-
ing B cells. The latent virus can be reactivated by cross-
linking of the B-cell antigen receptor [79,80]. Reactivation
of latent EBV proceeds through three MEF2-binding
sites in the promoter for the immediate-early gene
BZLF1, which encodes the transcriptional activator
ZEBRA. MEF2-dependent transcription of BZLF1 is
activated by Ca2þ flux; a similar mechanism governs
transcription of the Nur77 promoter in T cells [81]. In a
B-cell line carrying latent EBV, transfection of HDAC4– or
HDAC5–VP16 fusions reactivates viral expression [82].
These results indicate that EBV latency, like myogenesis
and Nur77 expression, is regulated by a Ca2þ-dependent
MEF2 switch in which class IIa HDACs mediate basal
repression.
TIGS 54
Review TRENDS in Genetics Vol.not known No.not known Month 00004
ARTICLE IN PRESS
http://tigs.trends.com
The class IIb HDACs: HDAC6 and HDAC10
Class IIb HDACs are characterized by duplicated HDAC
domains, although this duplication is partial in the case
of HDAC10 (Fig. 1b). Class IIb HDACs also show some
degree of tissue-specific gene expression: HDAC6 is pre-
dominantly expressed in testis [13,83], and HDAC10 is
expressed in liver, spleen and kidney [8,10,12]. Different
splice variants are observed for HDAC10, as shown for
HDAC3, -7 and -9, suggesting an additional level of regu-
lation by RNA processing. Analysis of the catalytic activity
of the two separate HDAC domains of HDAC6 by site-
directed mutagenesis suggested that the two domains
might function independently [5]; however, separation of
the two domains results in loss of enzymatic activity
(W. Fischle and E. Verdin, unpublished). In HDAC10, the
C-terminal catalytic domain lacks the active pocket resi-
dues required for enzymatic activity. The enzymatic
activities of HDAC6 and HDAC10 are more resistant to
trapoxin and sodium butyrate than those of class I and
class IIa HDACs [9,84]. Deletion of the second incomplete
catalytic domain of HDAC10 restores its sensitivity to both
sodium butyrate and trapoxin, suggesting that the two
HDAC domains functionally interact [9].
HDAC6 shuttles in and out of the cell nucleus. In the
absence of a stimulus, the majority of HDAC6 is localized
to the cytoplasm, but cell-cycle arrest is associated with
the partial translocation of the protein to the cell nucleus
[85]. HDAC10 is also primarily cytoplasmic but shows
significant nuclear staining in several cell lines [8–10,12].
The cytoplasmic location of both HDAC6 and HDAC10,
unlike that of class IIa HDACs, is insensitive to leptomycin B
[8,9,85]. The subcellular localization of HDAC6 is depen-
dent on a strong nuclear export signal (NES1) in the
N-terminus of the protein [85]. Several putative export
sequences were identified in HDAC10 [8,12], but it is not
known whether they function as true export signals.
HDAC6 is part of a multiprotein complex that includes
two mammalian orthologs of yeast proteins involved in the
control of protein ubiquitination: p97/VCP, a mammalian
homolog of yeast Cdc48p, and phospholipase A2 activating
protein, a homolog of yeast UFD3 (ubiquitin fusion degra-
dation protein 3) (Fig. 4) [83]. HDAC6 contains a C-terminal
zinc finger that shows significant homology to a zinc finger
located in several ubiquitin-specific proteases (ZnF-UBP)
[83] (Fig. 4). The ZnF-UBP motif (also identified as a
polyubiquitin-associated zinc finger or PAZ domain) [86]
mediates the binding of ubiquitin to HDAC6 [83,86]. The
specific interaction of proteins involved in protein ubiqui-
tination and the fact that both acetylation and ubiquitina-
tion target lysine residues suggest that HDAC6 could
participate in the deacetylation of proteins before their
ubiquitination.
Cytoplasmic HDAC6 shows striking co-localization
with the microtubule network [87,88]. Acetylation of
a-tubulin, at lysine 40, has been used as a marker of
microtubule stability [89]. HDAC6 functions as a
specific tubulin deacetylase in vivo, and purified HDAC6
deacetylates a-tubulin in assembled microtubules in vitro
[87,88]. HDAC6 overexpression promotes chemotactic
cell movement, a cellular function dependent on micro-
tubules. We have independently observed that SIRT2, a
NADþ-dependent class III HDAC, deacetylates lysine 40 of
Fig. 3. Regulation of Nur77 promoter activity in developing thymic T cells by class II histone deacetylases (HDACs). Class II HDACs, primarily HDAC7 in the thymus, repress
the latent activating potential of MEF2 transcription factors, both by preventing the binding of coactivators and by direct enzymatic activities associated with class IIa
HDACs. Elevation of intracellular Ca2þ levels, and possibly of kinases, through activation of the T-cell receptor in turn activates the Ca2þ sensor calmodulin (CaM), which
can directly displace class II HDACs from MEF2. In addition, CaM-dependent activation of Ca2þ/CaM-dependent protein kinases (CaMK) I and II results in the phosphoryl-
ation of the N-terminal domain of class II HDACs. Phosphorylated class IIa HDACs are displaced from MEF2, most probably because of conformational changes in the
interacting region. The 14-3-3 proteins bind to phosphorylated class II HDACs and mediate CRM1-dependent nuclear export, allowing the sustained expression of MEF2
target genes. For activation of transcription, coactivators (p300/CBP) and activators (NF-AT, ERK5) are recruited to the promoter. Unknown cytoplasmic phosphatases
dephosphorylate class II HDACs, leading to their release from 14-3-3 proteins.
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a-tubulin both in vitro and in vivo [56]. Both HDAC6 and
SIRT2 interact and co-localize in the cytoplasm with the
microtubule network (Fig. 4) [56]. Suppression of either
HDAC6 or SIRT2 mediated by siRNA leads to a relative
hyperacetylation of a-tubulin acetylation in vivo [56,87,88].
The identification of specific enzymes mediating tubulin
deacetylation should allow further work to proceed on
the role of this modification in microtubule dynamics
and functions.
Future questions
The purification, cloning and characterization of class II
HDACs have provided important insights into how chroma-
tin controls transcription and have revealed unexpected
biological functions for acetylation. The past two years
have seen the elucidation of discrete biological pathways
in which class II HDACs play crucial regulatory roles.
Whereas class IIa HDACs are frequently considered func-
tionally redundant, it is likely that further study will
reveal discrete biological functions specific for each family
member and its splice variants. Future studies should
focus on determining the relative contribution of each
HDAC in distinct cell types. By virtue of their ability to
interact with distinct transcription factors that each bind
at multiple sites in the genome, HDACs are likely to be
master regulators that control differentiation pathways.
Emphasis should therefore be placed on identifying the
subsets of genes controlled by individual HDACs in
various cell types. Genome-wide mapping of the histone
deacetylation targets of the yeast HDAC proteins (RPD3,
HDA1, Sir2, Hos1/3 and Hos2) has shown a clear division
of labor between these HDACs [90]. For example, of
815 genomic regions targeted by RPD3 and of 647 regions
targeted by HDA1, only 139 (,10%) are targeted by both
HDACs. Whereas most published work has focused on
nuclear HDACs acting on histone proteins, nonhistone
proteins are probable targets for these enzymes, as recently
illustrated for HDAC6 and tubulin.
A full understanding of the biology of class II HDACs
will also require a detailed analysis of how these factors
function biochemically as repressors of transcription.
Because HDACs have proved difficult to purify as enzym-
atically active proteins, little is known about their enzym-
atic specificity. It will be important to determine which
histones in the nucleosome and which lysine residues in
each histone are deacetylated by individual HDACs. Since
most HDACs reside in multiprotein complexes containing
several HDACs, the potential contribution of different
HDACs to enzymatic specificity will need to be addressed.
Finally, the identification of HDAC6 and SIRT2 as part
of a single complex with tubulin deacetylase activity
raises many new questions. The involvement of the
HDAC6/SIRT2 complex in both tubulin deacetylation
and protein ubiquitination suggests the existence of
cross-talk between these two processes, a dialogue that
is likely to be repeated in many proteins that are regulated
by ubiquitination. A focus on in vivo experiments, includ-
ing the development of a mouse knockout for each HDAC,
together with a renewed effort to characterize the enzym-
atic activities of these proteins, will allow these important
questions to be addressed.
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